Dimethyldithiocarbamate_NN
inhibits_VBZ
in_FW
vitro_FW
activation_NN
of_IN
primary_JJ
human_JJ
CD4_NN
+_CC
T_NN
lymphocytes_NNS
._.

Dithiocarbamates_NNS
-LRB-_-LRB-
DTC_NN
-RRB-_-RRB-
,_,
a_DT
diverse_JJ
group_NN
of_IN
industrial_JJ
and_CC
therapeutic_JJ
chemicals_NNS
,_,
have_VBP
been_VBN
reported_VBN
to_TO
inhibit_VB
,_,
enhance_VB
or_CC
have_VB
no_DT
effect_NN
on_IN
the_DT
immune_JJ
system_NN
._.

These_DT
apparent_JJ
inconsistencies_NNS
reflect_VBP
the_DT
complexity_NN
of_IN
the_DT
DTCs_JJ
biological_JJ
activities_NNS
and_CC
are_VBP
probably_RB
due_JJ
in_IN
part_NN
to_TO
differences_NNS
in_IN
dose_NN
,_,
route_NN
of_IN
exposure_NN
,_,
animal_JJ
species_NNS
used_VBN
and\/or_CC
specific_JJ
compound_NN
tested_VBN
._.

The_DT
studies_NNS
described_VBN
herein_RB
were_VBD
undertaken_VBN
to_TO
investigate_VB
the_DT
immunotoxicity_NN
of_IN
one_CD
member_NN
of_IN
this_DT
family_NN
,_,
dimethyldithiocarbamate_NN
-LRB-_-LRB-
DMDTC_NN
-RRB-_-RRB-
._.

We_PRP
demonstrate_VBP
that_IN
0.1_CD
-0.5_CD
microM_NN
DMDTC_NN
inhibits_VBZ
TNF-alpha-induced_JJ
activation_NN
of_IN
NF-kappaB_NN
in_IN
primary_JJ
human_JJ
CD4_NN
+_CC
T_NN
cells_NNS
._.

This_DT
inhibition_NN
is_VBZ
not_RB
accompanied_VBN
by_IN
a_DT
loss_NN
in_IN
viability_NN
,_,
and_CC
DMDTC-treated_JJ
T_NN
cells_NNS
retain_VBP
other_JJ
active_JJ
signaling_NN
pathways_NNS
throughout_IN
the_DT
exposure_NN
duration_NN
._.

The_DT
inhibition_NN
of_IN
NF-kappaB_NN
is_VBZ
apparently_RB
permanent_JJ
as_IN
DMDTC-treated_JJ
T_NN
cells_NNS
did_VBD
not_RB
regain_VB
normal_JJ
TNF-alpha_NN
activation_NN
,_,
even_RB
after_IN
72_CD
h_NN
in_IN
culture_NN
._.

DMDTC_NN
does_VBZ
not_RB
appear_VB
to_TO
alter_VB
NF-kappaB_NN
directly_RB
as_IN
pre-incubation_NN
of_IN
nuclear_JJ
extracts_NNS
with_IN
DMDTC_NN
does_VBZ
not_RB
diminish_VB
binding_NN
activity_NN
of_IN
this_DT
protein_NN
._.

We_PRP
further_RB
demonstrate_VBP
that_IN
0.1_CD
-0.5_CD
microM_NN
DMDTC_NN
inhibits_VBZ
intracellular_JJ
IL-2_NN
production_NN
and_CC
decreases_VBZ
surface_NN
expression_NN
of_IN
CD25_NN
-LRB-_-LRB-
the_DT
alpha_NN
subunit_NN
of_IN
the_DT
IL-2_NN
receptor_NN
-RRB-_-RRB-
in_IN
T_NN
cells_NNS
stimulated_VBN
with_IN
phorbol_NN
ester_NN
._.

These_DT
data_NNS
demonstrate_VBP
that_IN
DMDTC_NN
is_VBZ
a_DT
potent_JJ
immunosuppressive_JJ
compound_NN
in_FW
vitro_FW
._.

